Virilizing ovarian tumor of low malignant potential associated with antecedent tamoxifen use for breast cancer

Gynecol Oncol. 1998 Mar;68(3):293-6. doi: 10.1006/gyno.1998.4935.

Abstract

A patient is described who was treated with tamoxifen for breast cancer and developed an androgen-producing ovarian tumor of low malignant potential, which itself is a rare condition. Clinically overt virilism was leading to the diagnosis and promptly improved after surgical removal of the tumor. A causal relationship between tamoxifen use and the tumor is discussed on the basis of the known tumor-inducing potential of tamoxifen.

Publication types

  • Case Reports

MeSH terms

  • Androgens / biosynthesis
  • Androgens / blood
  • Antineoplastic Agents, Hormonal / adverse effects*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Epithelium / pathology
  • Female
  • Humans
  • Middle Aged
  • Neoplasms, Second Primary / chemically induced*
  • Neoplasms, Second Primary / complications
  • Neoplasms, Second Primary / pathology
  • Ovarian Neoplasms / chemically induced*
  • Ovarian Neoplasms / complications*
  • Ovarian Neoplasms / pathology
  • Tamoxifen / adverse effects*
  • Tamoxifen / therapeutic use
  • Virilism / blood
  • Virilism / etiology*

Substances

  • Androgens
  • Antineoplastic Agents, Hormonal
  • Tamoxifen